Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$46.36 - $52.63 $7,139 - $8,105
-154 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$41.54 - $47.25 $1,786 - $2,031
-43 Reduced 21.83%
154 $7,000
Q3 2018

Nov 16, 2018

BUY
$46.76 - $51.24 $9,211 - $10,094
197 New
197 $9,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $190B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bramshill Investments, LLC Portfolio

Follow Bramshill Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bramshill Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bramshill Investments, LLC with notifications on news.